Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Harper

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Cell Biology|December 1, 1994
Cdk inhibitors: on the threshold of checkpoints and developmentS J Elledge, J W Harper
Experimental Neurology|March 1, 1976
Descending projections of the rostral septal region: an electrophysiological-histological study in the catR G Heath, J W Harper
Biochemistry|December 3, 1985
Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitorsJ W Harper, J C Powers
Biochemistry|February 21, 1989
A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesisJ W Harper, B L Vallee
Biochemistry|January 26, 1988
Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinityJ W Harper, R R Lobb
The Journal of Clinical Investigation|December 22, 1999
Anticancer drug targets: cell cycle and checkpoint controlG I Shapiro, J W Harper
Experimental Neurology|February 1, 1974
Ascending projections of the cerebellar fastigial nuclei: connections to the ectosylvian gyrusJ W Harper, R G Heath
Nature Cell Biology|November 13, 1999
Skipping into the E2F1-destruction pathwayJ W Harper, S J Elledge
Journal of Protein Chemistry|August 1, 1988
Conformational characterization of human angiogenin by limited proteolysisJ W Harper, B L Vallee
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogeninJ W Harper, B L Vallee
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Cell Biology|December 1, 1994
Cdk inhibitors: on the threshold of checkpoints and developmentS J Elledge, J W Harper
Experimental Neurology|March 1, 1976
Descending projections of the rostral septal region: an electrophysiological-histological study in the catR G Heath, J W Harper
Biochemistry|December 3, 1985
Reaction of serine proteases with substituted 3-alkoxy-4-chloroisocoumarins and 3-alkoxy-7-amino-4-chloroisocoumarins: new reactive mechanism-based inhibitorsJ W Harper, J C Powers
Biochemistry|February 21, 1989
A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesisJ W Harper, B L Vallee
Biochemistry|January 26, 1988
Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinityJ W Harper, R R Lobb
The Journal of Clinical Investigation|December 22, 1999
Anticancer drug targets: cell cycle and checkpoint controlG I Shapiro, J W Harper
Experimental Neurology|February 1, 1974
Ascending projections of the cerebellar fastigial nuclei: connections to the ectosylvian gyrusJ W Harper, R G Heath
Nature Cell Biology|November 13, 1999
Skipping into the E2F1-destruction pathwayJ W Harper, S J Elledge
Journal of Protein Chemistry|August 1, 1988
Conformational characterization of human angiogenin by limited proteolysisJ W Harper, B L Vallee
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1988
Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogeninJ W Harper, B L Vallee
Pageof 11